iRhythm Technologies (IRTC)

• Market cap: $3.39B
• 1 day: 1.25%
• 5 days: 11.14%
• 1 month: 18.46%
• 3 months: 73.36%
• 6 months: 7.06%
• Year to date: 21.12%
• 1 year: -2.01%
• 5 years: 27.46%
• 10 years: 315.85%
• Sector: Healthcare
• Industry: Surgical & Medical Instruments & Apparatus

About: iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio includes ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for several days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States.

Employees: 2,000

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

64% more call options, than puts

Call options by funds: $66.8M | Put options by funds: $40.8M

53% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 32

28% more repeat investments, than reductions

Existing positions increased: 86 | Existing positions reduced: 67

6% more funds holding

Funds holding: 225 [Q2] → 238 (+13) [Q3]

5.58% less ownership

Funds ownership: 118.35% [Q2] → 112.76% (-5.58%) [Q3]

34% less capital invested

Capital invested by funds: $3.96B [Q2] → $2.61B (-$1.35B) [Q3]

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $79 27% downside
• Avg. target: $110 2% upside
• High target: $152 40% upside

6 analyst ratings

• positive: 5 83%
• neutral: 1 17%
• negative: 0 0%

Needham David Saxon 34% 1-year accuracy 21 / 62 met price target	3% upside $112	Buy Maintained	13 Jan 2025
Oppenheimer Suraj Kalia 61% 1-year accuracy 14 / 23 met price target	11% upside $120	Outperform Maintained	8 Jan 2025
Truist Securities Richard Newitter 79% 1-year accuracy 33 / 42 met price target	2% upside $111	Buy Maintained	18 Dec 2024
Canaccord Genuity William Plovanic 72% 1-year accuracy 34 / 47 met price target	40% upside $152	Buy Maintained	9 Dec 2024
Wells Fargo Nathan Treybeck 75% 1-year accuracy 3 / 4 met price target	21% downside $86	Equal-Weight Reinstated	3 Dec 2024